In contrast, Notch signaling alone is sufficient to activate the ERK1/2 pathway that negatively regulates the transcription of PPARG. Notch1 activation has been reported to increase ERK1/2 expression in HER2+ breast cancer by suppressing PTEN expression [45]. The gene discussed is MAPK3; the disease is breast carcinoma.